# Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial

> **NCT00551577** · PHASE2 · UNKNOWN · sponsor: **University Hospital, Bonn** · enrollment: 100 (estimated)

## Conditions studied

- Ovarian Neoplasms

## Interventions

- **PROCEDURE:** neoadjuvant chemotherapy (Carboplatin/Docetaxel)
- **PROCEDURE:** neoadjuvant chemotherapy (Carboplatin/Docetaxel)

## Key facts

- **NCT ID:** NCT00551577
- **Lead sponsor:** University Hospital, Bonn
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-03
- **Primary completion:** —
- **Final completion:** 2008-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2007-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00551577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00551577, "Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00551577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*